ID
12750
Description
EUropean survey on the assessment of deep molecular REsponse in chronic phase CML patients after at least two years of therapy with tyrosine KinAse inhibitors - major component of the Path to Cure Pillar of EUTOS III. ODM derived from: http://www.eutos.org/content/path_to_cure/eureka/index_eng.html
Link
http://www.eutos.org/content/path_to_cure/eureka/index_eng.html
Keywords
Versions (5)
- 12/16/15 12/16/15 -
- 12/19/15 12/19/15 -
- 12/19/15 12/19/15 -
- 12/20/15 12/20/15 -
- 1/3/16 1/3/16 -
Uploaded on
December 19, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Molecular Monitoring Survey EUREKA
Informed Consent Form
- StudyEvent: ODM
Description
Aim of the EUREKA-survey
Description
In an effort to constantly improving the treatment of CML, the EUREKA-survey is collecting and assessing medical data and molecular results of the measurement of the residual disease independent of a patients participation in a therapy study. The laboratories providing that particular data have special experience and fulfill certain quality assurance procedures. The data assessment shall give new insights into a European-wide availability of the standardized measurement of deep molecular response of CML. The results will be available for all CML patients that have been treated with tyrosine kinase inhibitor for at least two years. Biospecimen for the measurement of the residual disease (deoxyribonucleic acid, DNA; Ribonucleic acid, RNA) will be stored for a potential future reassessment with further developed methods.
Data type
integer
Alias
- UMLS CUI [1,1]
- C1947946
- UMLS CUI [1,2]
- C0008972
Description
Process of data collection
Description
The survey consist of a data acquisition alongside biomaterial collection. You will be fully informed about the therapy of your disease through your treating physician. Your treating physician will send survey documentation sheets comprising information about your disease, course of therapy and the result of the latest examination of the residual disease and your blood for the most recent analysis to the examination laboratory. There the data plus the results of the measurement will be entered into an electronic data acquisition system
Data type
integer
Alias
- UMLS CUI [1]
- C0262727
Description
Process of biomaterial collection
Description
The measurement of the residual disease during a CML therapy is a routine procedure. Therefore the EUREKA-survey does not require additional taking of blood samples. 20 ml. of peripheral blood will be sent to a national reference laboratory for the measurement of deep molecular response of CML. The biospecimen will be stored at the reference laboratory for an undefined period and if necessary used for scientific research purposes for further research into CML or for applying new methods of measurement of residual disease. All research projects where biospecimen from the EUREKA-biobank is used are examined and approved by the scientific panel of the EUREKA-survey. Furthermore all research projects have to be approved previously by an ethic commission.
Data type
integer
Alias
- UMLS CUI [1]
- C2347027
Description
Potential risks and benefits
Description
By providing your informed consent to data collection and biospecimen collection you can contribute to the development and distribution of new standardized detection methods. By doing so you also contribute to further improving the medical care of CML: By participating at the biobank you will receive the result of the measurement of residual disease from a laboratory that is participating at international studies on standardization and quality control. Your participation does not contain a direct personal benefit for your treatment. As the EUREKA-survey is a mere data collection survey and concomitantly biospecimen collection your participation does not involve any additional risk.
Data type
integer
Alias
- UMLS CUI [1]
- C0687742
Description
Information of data security
Description
In the context of the EUREKA-survey your personal and medical data will be anonymized and transferred to the respective lavatory from where it then will be further sent to the CML-study coordination office in Jena. The biospecimen are exclusively stored in a pseudonymized way by using a number code that does not allow any trace to your personal identification. Your data is treated confidentially and will not be passed on to third parties at any time. All personnel involved are subject to professional secrecy and your data underlies professional discretion and data protection. Analysis of the data collected are made exclusively pseudonymous. In case of a publication of study results (e.g. at conferences or in professional journals) no names will be stated and your personal identification will not be traceable. Even a disclosure of medical data or biospecimen to a third party (e.g. cooperating scientists) for scientific projects will be made pseudonymously. Your personal data will under no circumstances be disclosed to any third party. The collected data and biospecimen will be saved and stored indefinitely. Single specimen of the biobank can be destroyed in case they are not needed anymore. By providing your informed consent you agree to processing your personal data and biospecimen as descried above.
Data type
integer
Alias
- UMLS CUI [1]
- C0086100
Description
Voluntariness and withdrawl of consent
Description
Your participation at the EURKEA-survey and biobank is voluntarily. You can withdraw your consent at any time without stating a reason without penalty or loss of privilege. In that case no further data from you will be collected, medical data already collected will be deleted and your biospecimen will be destroyed.
Data type
integer
Alias
- UMLS CUI [1,1]
- C0680274
- UMLS CUI [1,2]
- C0586888
Description
Further information
Similar models
Informed Consent Form
- StudyEvent: ODM
C0008972 (UMLS CUI [1,2])
C0586888 (UMLS CUI [1,2])
No comments